SEC Tracker
Get the app

Foghorn Therapeutics FHTX

Foghorn Therapeutics: annual report (amended)

Form
10-K/A
Filed
Importance
Routine

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Foghorn Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Omeros OMER public float $172M, Jun 30, 2025
  2. Lexicon Pharmaceuticals LXRX public float $170M, Jun 30, 2025
  3. XOMA Royalty XOMA public float $168M, Jun 30, 2025
  4. Crescent Biopharma CBIO public float $177M, Jun 30, 2025
  5. 4D Molecular Therapeutics FDMT public float $166M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.